Increased cortical thickness and caudate volume precede atrophy in psen1 mutation carriers

Journal of Alzheimer's Disease

Volumn 22, Issue 3, 2010, Pages 909-922

  Fortea, Juan ^a   Sala Llonch, Roser ^b,c   Bartrés Faz, David ^b,c   Bosch, Beatriz ^a   Lladó, Albert ^a,c   Bargalló, Nuria ^a,c   Molinuevo, José Luis ^a,c   Sánchez Valle, Raquel ^a,c  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Alzheimer disease; amyloid; cerebrospinal fluid; magnetic resonance imaging; presenilin 1

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E; PRESENILIN 1;

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN CORTEX; BRAIN SIZE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE MUTATION; GRAY MATTER; HETEROZYGOTE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PARIETAL LOBE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; SUBCORTEX; TEMPORAL LOBE; VOXEL BASED MORPHOMETRY;

EID: 78649896021     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-100678     Document Type: Article

References (37)

1. Alzheimer Disease & Frontotemporal Dementia Mutation Database, , Accessed on February 2, 2010.
2. Mondadori CR, Buchmann A, Mustovic H, Schmidt CF, Boesiger P, Nitsch RM, Hock C, Streffer J, Henke K (2006). Enhanced brain activity may precede the diagnosis of Alzheimer's disease by 30 years. Brain 129, 2908-2922.
3. Godbolt AK, Waldman AD, MacManus DG, Schott JM, Frost C, Cipolotti L, Fox NC, Rossor MN (2006) MRS shows abnormalities before symptoms in familial Alzheimer disease. Neurology 66, 718-722.
4. Schott JM, Fox NC, Frost C, Scahill RI, Janssen JC, Chan D, Jenkins R, Rossor MN (2003) Assessing the onset of structural change in familial Alzheimer's disease. Ann Neurol 53, 181188.
5. Ridha BH, Barnes J, Bartlett JW, Godbolt A, Pepple T, Rossor MN, Fox NC (2006) Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study. Lancet Neurol 5, 828-834.
6. Mosconi L, Sorbi S, de Leon MJ, Li Y, Nacmias B, Myoung PS, Tsui W, Ginestroni A, Bessi V, Fayyazz M, Caffarra P, Pupi A (2006) Hypometabolism exceeds atrophy in presymp- tomatic early-onset familial Alzheimer's disease. J Nucl Med 47, 1778-1786.
7. Desikan RS, Cabral HJ, Hess CP, Dillon WP, Glastonbury CM, Weiner MW, Schmansky NJ, Greve DN, Salat DH, Buckner RL, Fischl B; Alzheimer's Disease Neuroimaging Initiative (2009) Alzheimer's Disease Neuroimaging Initiative. Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease. Brain 132, 2048-2057.
8. Dickerson BC, Bakkour A, Salat DH, Feczko E, Pacheco J, Greve DN, Grodstein F, Wright CI, Blacker D, Rosas HD, Sperling RA, Atri A, Growdon JH, Hyman BT, Morris JC, Fischl B, Buckner RL (2009) The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex 19, 497-510.
9. Knight WD, Kim LG, Douiri A, Frost C, Rossor MN, Fox NC (2010) Acceleration of cortical thinning in familial Alzheimer's disease. Neurobiol Aging, in press.
10. Muller MJ, Greverus D, Weibrich C, Dellani PR, Scheurich A, Stoeter P, Fellgiebel A (2007) Diagnostic utility of hippocam- pal size and mean diffusivity in amnestic MCI. Neurobiol Aging 28, 398-403.
11. Carlesimo GA, Cherubini A, Caltagirone C, SpallettaG (2010) Hippocampal mean diffusivity and memory in healthy elderly individuals: a cross-sectional study. Neurology 74, 194-200.
12. Sanchez-Valle R, Llado A, Ezquerra M, Rey MJ, Rami L, Molinuevo JL (2007) A novel mutation in the PSEN1 gene (L286P) associated with familial early-onset dementia of Alzheimer type and lobar haematomas. Eur J Neurol 14, 14091412.
13. Llado A, Fortea J, Ojea T, Bosch B, Sanz P, Valls-Sole J, Clari- mon J, Molinuevo JL, Sanchez-Valle R (Epub ahead of print) A novel PSEN1 mutation (K239N) associated with Alzheimer's disease with wide range age of onset and slow progression. Eur J Neurol 17, 994-996
14. Fischl B, Dale AM (2000) Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc NatlAcadSci USA 97, 11050-11055.
15. Desikan RS, Segone F, Fischl B, Quinn BT, Dickerson BC, Blacker D, Buckner RL, Dale AM, Maguire RP, Hyman BT, Albert MS, Killiany RJ (2006). An automated labelling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31, 968-980.
16. Fischl B, van der Kouwe A, Destrieux C, Halgren E, Segonne F, Salat DH, Busa E, Seidman LJ, Goldstein J, Kennedy D, Caviness V, Makris N, Rosen B, Dale AM (2004). Automatically parcellating the human cerebral cortex. Cereb Cortex 14, 11-22.
17. Buckner RL, Head D, Parker J, Fotenos AF, Marcus D, Morris JC, Snyder AZ (2004). A unified approach for morphomet- ric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume. Neuroimage 23, 724-738.
18. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE, Niazy RK, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady JM, Matthews PM (2004) Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23, S208-S219.
19. Whitwell JL, Shiung MM, Przybelski SA, Weigand SD, Knop- man DS, Boeve BF, Petersen RC, Jack CR Jr (2008) MRI patterns ofatrophy associated with progression to AD in amnestic mild cognitive impairment. Neurology 70, 512-520.
20. Eskildsen SF, Stergaard LR, Rodell AB, Stergaard L, Nielsen JE, Isaacs AM, Johannsen P (2009) Cortical volumes and atrophy rates in FTD-3 CHMP2B mutation carriers and related non-carriers. Neuroimage 45, 713-721.
21. Klunk WE, Price JC, Mathis CA, Tsopelas ND, Lopresti BJ, Ziolko SK, Bi W, Hoge JA, Cohen AD, Ikonomovic MD, Sax- ton JA, Snitz BE, Pollen DA, Moonis M, Lippa CF, Swearer JM, Johnson KA, Rentz DM, Fischman AJ, Aizenstein HJ, DeKosky ST (2007) Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J Neurosci 27, 6174-6184.
22. Villemagne VL, Ataka S, Mizuno T, Brooks WS, Wada Y, Kon- do M, Jones G, Watanabe Y, Mulligan R, Nakagawa M, Miki T, Shimada H, O'Keefe GJ, Masters CL, Mori H, Rowe CC (2009) High striatal amyloid beta-peptide deposition across different autosomal Alzheimer disease mutation types. Arch Neurol 66, 1537-1544.
23. Espeseth T, Westlye LT, Fjell AM, Walhovd KB, Rootwelt H, Reinvang I (2008) Accelerated age-related cortical thinning in healthy carriers of apolipoprotein E epsilon 4. Neurobiol Aging 29, 329-340.
24. Espeseth T, Westlye LT, Walhovd KB, Fjell AM, Endestad T, Rootwelt H, Reinvang I (2010) Apolipoprotein E epsilon4- related thickening of the cerebral cortex modulates selective attention. Neurobiol Aging, in press.
25. Riudavets MA, Iacono D, Resnick SM, O'Brien R, Zonderman AB, Martin LJ, Rudow G, Pletnikova O, Troncoso JC (2007) Resistance to Alzheimer's pathology is associated with nuclear hypertrophy in neurons. Neurobiol Aging 28, 1484-1492.
26. Iacono D, Markesbery WR, Gross M, Pletnikova O, Rudow G, Zandi P, Troncoso JC (2009) The Nun study: clinically silent AD, neuronal hypertrophy, and linguistic skills in early life. Neurology 73, 665-673.
27. West MJ, Bach G, Sederman A, Jensen JL (2009) Synap- tic contact number and size in stratum radiatum CA1 of APP/PS1DeltaE9 transgenic mice. Neurobiol Aging 30, 1756-1776.
28. Oh ES, Savonenko AV, King JF, Fangmark Tucker SM, Rudow GL, Xu G, Borchelt DR, Troncoso JC (2009) Amyloid precursor protein increases cortical neuron size in transgenic mice. Neurobiol Aging 30, 1238-1244.
29. Maheswaran S, Barjat H, Rueckert D, Bate ST, Howlett DR, Tilling L, Smart SC, Pohlmann A, Richardson JC, Hartkens T, Hill DL, Upton N, Hajnal JV, James MF (2009) Longitudinal regional brain volume changes quantified in normal aging and Alzheimer's APP x PS 1 mice using MRI. Brain Res 1270, 19-32.
30. Zanjani H, Finch CE, Kemper C, Atkinson J, McKeel D, Morris JC, Price JL (2005) Complement activation in very early Alzheimer disease. Alzheimer Dis Assoc Disord 19, 55-66.
31. Fox NC, Black RS, Gilman S, Rossor MN, Griffith SG, Jenkins L, Koller M; AN1792(QS-21)-201 Study (2005) Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease. Neurology 64, 1563-1572.
32. Sotak CH. Nuclear magnetic resonance (NMR) measurement ofthe apparent diffusion coefficient (ADC) oftissue water and its relationship to cell volume changes in pathological states. Neurochem Int 45, 569-582.
33. Paulsen JS, Magnotta VA, Mikos AE, Paulson HL, Penziner E, Andreasen NC, Nopoulos PC (2006) Brain structure in preclinical Huntington's disease. Biol Psychiatry 59, 57-63.
34. Lerch JP, Carroll JB, Dorr A, Spring S, Evans AC, Hayden MR, Sled JG, Henkelman RM (2008) Cortical thickness measured from MRI in the YAC128 mouse model of Huntington's disease. Neuroimage 41, 243-251.
35. Gomez-Tortosa E, MacDonald ME, Friend JC, Taylor SA, Weiler LJ, Cupples LA, Srinidhi J, Gusella JF, Bird ED, Von- sattel JP, Myers RH (2001) Quantitative neuropathological changes in presymptomatic Huntington's disease. Ann Neurol 49, 29-34.
36. Fagan AM, Mintun MA, Mach RH, Lee SY, Dence CS, Shah AR, LaRossa GN, Spinner ML, Klunk WE, Mathis CA, DeKosky ST, Morris JC, Holtzman DM (2006) Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Ann Neurol 59, 512-59.
37. Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ (2010) Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 9, 119-128.